Pharmacotherapy (@pharmacojournal) 's Twitter Profile
Pharmacotherapy

@pharmacojournal

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy is an official journal of @ACCP.

ID: 3676385722

linkhttps://accpjournals.onlinelibrary.wiley.com/journal/18759114 calendar_today16-09-2015 16:01:19

3,3K Tweet

11,11K Followers

287 Following

Antibiotic Steward Bassam Ghanem ๐Ÿ…ฑ๏ธC๐Ÿ†”๐Ÿ…ฟ๏ธ๐ŸŒŸ (@absteward) 's Twitter Profile Photo

Better together? ๐Ÿ†•๐Ÿ’ซLarge multi-hospital cohort Brent Footer Implementation of a blended vanco dosing approach* with a majority of AUC-based dosing resulted in a statistically & clinically significant reduction in cumulative vanco dose & risk of AKI accpjournals.onlinelibrary.wiley.com/doi/abs/10.100โ€ฆ

Better together?
๐Ÿ†•๐Ÿ’ซLarge multi-hospital cohort <a href="/BrentFooter/">Brent Footer</a>
Implementation of a blended vanco dosing approach* with a majority of AUC-based dosing resulted in a statistically &amp; clinically significant reduction in cumulative vanco dose &amp; risk of AKI
accpjournals.onlinelibrary.wiley.com/doi/abs/10.100โ€ฆ
Pharmacotherapy (@pharmacojournal) 's Twitter Profile Photo

Although cysC may be useful in hospitalized patients, the use of cysC to calculate drug dosing in critically ill patients has been incompletely investigated. OPEN ACCESS: buff.ly/lanfJfW

Although cysC may be useful in hospitalized patients, the use of cysC to calculate drug dosing in critically ill patients has been incompletely investigated. OPEN ACCESS: buff.ly/lanfJfW
Pharmacotherapy (@pharmacojournal) 's Twitter Profile Photo

To meet the goal of ending the HIV epidemic, optimized use of the drugs routinely used for treatment and prevention is necessary and DBS monitoring represents a potential way to increase the likelihood of meeting this ambitious goal. buff.ly/9QZpOUc

To meet the goal of ending the HIV epidemic, optimized use of the drugs routinely used for treatment and prevention is necessary and DBS monitoring represents a potential way to increase the likelihood of meeting this ambitious goal. buff.ly/9QZpOUc
Pharmacotherapy (@pharmacojournal) 's Twitter Profile Photo

This emerging evidence supports the utility of GLP-1 RAs as a potential disease-modifying option for OA, offering a dual benefit in metabolic and joint health. buff.ly/jryH9PL

This emerging evidence supports the utility of GLP-1 RAs as a potential disease-modifying option for OA, offering a dual benefit in metabolic and joint health. buff.ly/jryH9PL
Pharmacotherapy (@pharmacojournal) 's Twitter Profile Photo

Is there a significant change in potassium levels with sodium-glucose co-transporter-2 (SGLT2) inhibitor therapy in people with type 2 diabetes (T2D)? buff.ly/q8lgd6Q

Is there a significant change in potassium levels with sodium-glucose co-transporter-2 (SGLT2) inhibitor therapy in people with type 2 diabetes (T2D)? buff.ly/q8lgd6Q
Pharmacotherapy (@pharmacojournal) 's Twitter Profile Photo

Although GLP-1RAs are generally not associated with drugโ€“drug interactions via drug metabolism or transporter pathways, their effects on reduced gastrointestinal motility could influence the pharmacokinetics of coadministered oral medications. OPEN ACCESS: buff.ly/ZeDOZVH

Although GLP-1RAs are generally not associated with drugโ€“drug interactions via drug metabolism or transporter pathways, their effects on reduced gastrointestinal motility could influence the pharmacokinetics of coadministered oral medications. OPEN ACCESS: buff.ly/ZeDOZVH
Pharmacotherapy (@pharmacojournal) 's Twitter Profile Photo

Although GLP-1RAs are generally not associated with drugโ€“drug interactions via drug metabolism or transporter pathways, their effects on reduced gastrointestinal motility could influence the pharmacokinetics of coadministered oral medications. OPEN ACCESS: buff.ly/XFTam1S

Although GLP-1RAs are generally not associated with drugโ€“drug interactions via drug metabolism or transporter pathways, their effects on reduced gastrointestinal motility could influence the pharmacokinetics of coadministered oral medications. OPEN ACCESS: buff.ly/XFTam1S
Pharmacotherapy (@pharmacojournal) 's Twitter Profile Photo

Utilizing serum clozapine levels may be helpful in guiding dose changes during antipsychotic cross-titration, especially when multiple drug interactions are involved. buff.ly/k08qKYk

Utilizing serum clozapine levels may be helpful in guiding dose changes during antipsychotic cross-titration, especially when multiple drug interactions are involved. buff.ly/k08qKYk
Pharmacotherapy (@pharmacojournal) 's Twitter Profile Photo

Results from this study support the need to create medication management programs to decrease exposure to potentially inappropriate prescribed medications. OPEN ACCESS: buff.ly/bnPaRj7

Results from this study support the need to create medication management programs to decrease exposure to potentially inappropriate prescribed medications. OPEN ACCESS: buff.ly/bnPaRj7
Pharmacotherapy (@pharmacojournal) 's Twitter Profile Photo

The concurrent use of thiazide diuretics and SSRIs is associated with an increased risk of hyponatremia in older populations. OPEN ACCESS: buff.ly/e9NKcTG

The concurrent use of thiazide diuretics and SSRIs is associated with an increased risk of hyponatremia in older populations. OPEN ACCESS: buff.ly/e9NKcTG
SCCM Clinical Pharmacy and Pharmacology Section (@sccm_cpp) 's Twitter Profile Photo

โœจ #CPPPLU Highlights: This systematic review from Pharmacotherapy found when patients received IV thrombolytics while on DOACs there was no difference in in-hospital mortality compared to those not receiving DOACs (OR 0.94, 95% CI [0.44-2]). loom.ly/OxcMDkE #PharmICU

โœจ #CPPPLU Highlights:
This systematic review from <a href="/PharmacoJournal/">Pharmacotherapy</a> found when patients received IV thrombolytics while on DOACs there was no difference in in-hospital mortality compared to those not receiving DOACs (OR 0.94, 95% CI [0.44-2]).
loom.ly/OxcMDkE
#PharmICU
Pharmacotherapy (@pharmacojournal) 's Twitter Profile Photo

The primary focus of this review is on newly approved antibiotics, along with any additional published evidence on previously reviewed antibiotics. OPEN ACCESS: buff.ly/O9uFmoq

The primary focus of this review is on newly approved antibiotics, along with any additional published evidence on previously reviewed antibiotics. OPEN ACCESS: buff.ly/O9uFmoq
Dr.Marlon Villanuevaโ„ข ๐Ÿฉบ ๐• (@marlonvfzr) 's Twitter Profile Photo

โ€ผ๏ธโ™ป๏ธ๐—ฆ๐—ฒ๐—ด๐˜‚๐—ฟ๐—ถ๐—ฑ๐—ฎ๐—ฑ ๐—ฑ๐—ฒ ๐—ฎ๐—ป๐˜๐—ถ๐—ฏ๐—ถ๐—ผฬ๐˜๐—ถ๐—ฐ๐—ผ๐˜€ ๐—ฑ๐˜‚๐—ฟ๐—ฎ๐—ป๐˜๐—ฒ ๐—ฒ๐—น ๐—ฒ๐—บ๐—ฏ๐—ฎ๐—ฟ๐—ฎ๐˜‡๐—ผ๐Ÿคฐ๐Ÿป Pharmacotherapy ๐Ÿ‘‡๐Ÿผ๐Ÿ‘‡๐Ÿผ๐Ÿ‘‡๐Ÿผ๐Ÿ‘‡๐Ÿผ๐Ÿ‘‡๐Ÿผ ๐Ÿ“‘๐Ÿ”—๐Ÿ”‘๐Ÿ”“ t.me/ClubCrit

Pharmacotherapy (@pharmacojournal) 's Twitter Profile Photo

The median insulin dose reduced from 101โ€‰units at baseline to 71โ€‰units after 6โ€‰months, with a median decrease of 9.5โ€‰units (pโ€‰<โ€‰0.001). buff.ly/5OODLAW

The median insulin dose reduced from 101โ€‰units at baseline to 71โ€‰units after 6โ€‰months, with a median decrease of 9.5โ€‰units (pโ€‰&lt;โ€‰0.001). buff.ly/5OODLAW
Pharmacotherapy (@pharmacojournal) 's Twitter Profile Photo

In this large multi-hospital cohort, the implementation of a blended dosing method using a majority of AUC-based dosing reduced cumulative vancomycin doses, serum levels, and AKI. buff.ly/nYIqxWd

In this large multi-hospital cohort, the implementation of a blended dosing method using a majority of AUC-based dosing reduced cumulative vancomycin doses, serum levels, and AKI. buff.ly/nYIqxWd
Shoaib Alam (@shoaibalamkhat2) 's Twitter Profile Photo

Surprising turn: Korean cohort study backs #dapagliflozin for kidney safetyโ€”contrary to FDA's caution! ๐Ÿ‡ฐ๐Ÿ‡ท Nationwide data shows 34% reduced #AKI risk with dapagliflozin vs. sitagliptin. Published: Pharmacotherapy #Diabetes #Research #Nephrology #Pharmacy accpjournals.onlinelibrary.wiley.com/doi/full/10.10โ€ฆ

Pharmacotherapy (@pharmacojournal) 's Twitter Profile Photo

These studies describe a substantial and growing body of evidence focused on improving the management of CKD beyond renin-angiotensin system inhibitors, such as angiotensin-converting enzyme inhibitors & angiotensin receptor blockers. buff.ly/Lp6Olvh

These studies describe a substantial and growing body of evidence focused on improving the management of CKD beyond renin-angiotensin system inhibitors, such as angiotensin-converting enzyme inhibitors &amp; angiotensin receptor blockers. buff.ly/Lp6Olvh
Pharmacotherapy (@pharmacojournal) 's Twitter Profile Photo

This themed issue aims to disseminate new knowledge on the unique challenges of pharmacotherapy facing clinicians and their female patients in the realm of oncology. buff.ly/sGEZq8d

This themed issue aims to disseminate new knowledge on the unique challenges of pharmacotherapy facing clinicians and their female patients in the realm of oncology. buff.ly/sGEZq8d
Pharmacotherapy (@pharmacojournal) 's Twitter Profile Photo

PK modeling successfully standardized ARV CSF concentrations to a given time point (i.e., CMAX or CTrough) to allow estimation of CSF penetration. buff.ly/KGpDxbJ

PK modeling successfully standardized ARV CSF concentrations to a given time point (i.e., CMAX or CTrough) to allow estimation of CSF penetration. buff.ly/KGpDxbJ
Pharmacotherapy (@pharmacojournal) 's Twitter Profile Photo

Contrary to the United States Food and Drug Administration's safety warning, our findings suggest that dapagliflozin may have a protective effect against AKI in patients with T2DM. OPEN ACCESS: buff.ly/CdHsc8y

Contrary to the United States Food and Drug Administration's safety warning, our findings suggest that dapagliflozin may have a protective effect against AKI in patients with T2DM. OPEN ACCESS: buff.ly/CdHsc8y